These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 21905508

  • 1. An immediate hypersensitivity reaction caused by tolperisone hydrochloride.
    Glück J, Rymarczyk B, Rogala B.
    J Investig Allergol Clin Immunol; 2011; 21(5):411-2. PubMed ID: 21905508
    [No Abstract] [Full Text] [Related]

  • 2. [Mydocalm causing anaphylaxis].
    Kwaśniewski A, Korbuszewska-Gontarz B, Mika S.
    Pneumonol Alergol Pol; 2003; 71(5-6):250-2. PubMed ID: 14587432
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial.
    Dulin J, Kovács L, Ramm S, Horvath F, Ebeling L, Kohnen R.
    Pharmacopsychiatry; 1998 Jul; 31(4):137-42. PubMed ID: 9754848
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial].
    Lipták J.
    Ideggyogy Sz; 2013 Jul 30; 66(7-8):283-4. PubMed ID: 23971362
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force--a double-blind randomized crossover control study.
    Bajaj P, Arendt-Nielsen L, Madeleine P, Svensson P.
    Eur J Pain; 2003 Jul 30; 7(5):407-18. PubMed ID: 12935792
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial.
    Pratzel HG, Alken RG, Ramm S.
    Pain; 1996 Oct 30; 67(2-3):417-25. PubMed ID: 8951937
    [Abstract] [Full Text] [Related]

  • 7. [To make easier everyday life of stroke patients. Muscle relaxants diminish spasms].
    MMW Fortschr Med; 2003 Feb 27; 145(9):57. PubMed ID: 12666538
    [No Abstract] [Full Text] [Related]

  • 8. Anaphylaxis caused by tetrazepam without cross-reactivity with other benzodiazepines.
    Martínez-Tadeo JA, Pérez-Rodríguez E, Hernández-Santana G, García-Robaina JC, de la Torre-Morín F.
    Ann Allergy Asthma Immunol; 2012 Apr 27; 108(4):284-5. PubMed ID: 22469453
    [No Abstract] [Full Text] [Related]

  • 9. Tolperisone: evaluation of the lidocaine-like activity by molecular modeling.
    Fels G.
    Arch Pharm (Weinheim); 1996 Apr 27; 329(4):171-8. PubMed ID: 8669981
    [Abstract] [Full Text] [Related]

  • 10. A phase IV observational multi-centre, open-label study on efficacy and safety of tolperisone 150 mg in patients with painful muscle spasm associated with degenerative or inflammatory diseases of the musculoskeletal system.
    Prabhoo R, Keny S, Prabhoo T, Singh A, Rana R.
    J Assoc Physicians India; 2011 Jan 27; 59():33-7. PubMed ID: 21751662
    [Abstract] [Full Text] [Related]

  • 11. [The results of the multicenter pharmaco-epidemiological observational project on the use of mydocalm in the treatment of pain syndromes with the muscle spasm].
    Skoromets AA, Guekht AB, Galanov DV, Danilenko OA, Barantsevich ER, Lebedeva AV, Belova AN, Shprakh VV, Bogdanov EI, Prokopenko SV, Khabirov FA, Spirin NN, Baliazin VA, Miakotnykh VS, Volkova LI, Gafurov BG, Mishchenko TS, Toktomushev CT, Shyralieva RK, Musaev SK, Guseinov SG.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Jan 27; 115(12):104-109. PubMed ID: 26978502
    [Abstract] [Full Text] [Related]

  • 12. Erythema multiforme to tetrazepam.
    Cabrerizo Ballesteros S, Méndez Alcalde JD, Sánchez Alonso A.
    J Investig Allergol Clin Immunol; 2007 Jan 27; 17(3):205-6. PubMed ID: 17583114
    [No Abstract] [Full Text] [Related]

  • 13. Anaphylactic reactions to tolperisone (Mydocalm).
    Ribi C, Vermeulen C, Hauser C.
    Swiss Med Wkly; 2003 Jun 28; 133(25-26):369-71. PubMed ID: 12947534
    [Abstract] [Full Text] [Related]

  • 14. Stereochemical study of tolperisone, a muscle relaxant agent, by circular dichroism and ultraviolet spectroscopy.
    Zsila F, Hollósi M, Gergely A.
    Chirality; 2000 Nov 28; 12(10):720-6. PubMed ID: 11054830
    [Abstract] [Full Text] [Related]

  • 15. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
    Kocsis P, Tarnawa I, Kovács G, Szombathelyi Z, Farkas S.
    Acta Pharm Hung; 2002 Nov 28; 72(1):49-61. PubMed ID: 12426787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eczematous dermatitis caused by tetrazepam.
    Vázquez-Cortés S, Davila Fernández G, Elices Apellaniz A, Nieto Llanos S, Chamorro Gómez M.
    Allergol Immunopathol (Madr); 2013 Nov 28; 41(1):64-5. PubMed ID: 21968006
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative effciency of bakloferon and tolperizon central muscle relaxants in complex therapy of back pain].
    Vorob'eva OV, Kozlova IM.
    Voen Med Zh; 2006 Sep 28; 327(9):52-5. PubMed ID: 17180860
    [No Abstract] [Full Text] [Related]

  • 19. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.
    Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W.
    CNS Neurosci Ther; 2008 Sep 28; 14(2):107-19. PubMed ID: 18482024
    [Abstract] [Full Text] [Related]

  • 20. Results of the post-registration clinical study "PARUS" on efficiency and safety assessment of Mydocalm-Richter for local injection therapy of a myofascial trigger zone.
    Devlikamova FI.
    Ter Arkh; 2018 Jun 20; 90(6):81-88. PubMed ID: 30701909
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.